Saturday, December 3, 2022
Spot_Img

ACQUISITIONS and MERGERS

Boston Scientific Announces Agreement to Acquire Apollo Endosurgery, Inc.

"Endoluminal surgery is an emerging field and a core focus for our Endoscopy business," said Mike Jones, senior vice president and president, Endoscopy, Boston Scientific. "We intend to expand our global capabilities in ELS with the differentiated innovation that Apollo Endosurgery offers, and we will continue to focus on procedural adoption as well as professional education in this exciting space. This acquisition also enables us to enter a new adjacency – the endobariatric market – and deliver strong, continued growth across our business."

Momentis Announces First Adoption of Anovo™ Surgical System in Texas by Medical City Plano

Dvir Cohen, CEO and Co-Founder of Momentis. “In the months ahead, we will continue our efforts to broaden availability of the system and improve gynecological surgery to enable more surgeons to perform the clinically preferred transvaginal approach, setting a higher standard in women’s healthcare.”

Momentis Announces HCA Oviedo Medical Center Acquires Anovo Surgical System

The Anovo Surgical System is the first and only FDA-authorized surgical robot with features including shoulder, elbow, and wrist joints designed to mimic human arms and provide human level dexterity.

Cordis Announces Acquisition of MedAlliance

By acquiring MedAlliance, Cordis has the potential to serve two million patients globally by 2027 with the SELUTION SLR™ (Sustained Limus Release) drug-eluting balloon.

Sebia Acquires Zeus Scientific

Sebia advises Zeus Scientific, will provide synergies and expand their capabilities and product portfolio in autoimmunity, with a strong footprint in the United States.

CHS USA Inc. Acquires Medical Imaging Solutions International

"This acquisition is a great fit for CHS because we share similar qualities, values, capabilities and offerings. The MISI acquisition is a great platform for US expansion in the diagnostic imaging market," states Mike Canzoneri, President and CEO of CHS USA.

By using this website you agree to accept Medical Device News Magazine Privacy Policy